1678 reviews
A powerful platform built for active traders with advanced tools, customizable strategies, and futures trading—not ideal for passive dividend investors.
We include TradeStation for completeness, but it's important to state upfront: this platform is NOT designed for dividend investors.
TradeStation doesn't offer DRIP (dividend reinvestment) or fractional shares. These are essential features for building and compounding a dividend portfolio.
If you're focused on dividend investing, look elsewhere. TradeStation excels at active trading, not passive income strategies.
TradeStation is built for active, self-directed traders who need professional-grade tools. The platform offers extensive customization, backtesting, and automated strategy execution.
Features like RadarScreen scan markets in real-time, and the platform supports complex options strategies, futures, and day trading with favorable margin requirements.
If you're an active trader who also holds some dividend stocks, TradeStation can work. But you'll need to manually reinvest dividends and can only buy whole shares.
TradeStation's desktop platform is legendary among active traders. Hundreds of indicators, advanced charting, and the ability to create and backtest custom strategies.
EasyLanguage lets you code custom indicators and automated trading strategies. This level of customization is rare in retail platforms.
The web and mobile platforms are more accessible but still oriented toward active trading rather than long-term investing.
TS Select (main retail plan) includes $0 stock and ETF commissions for up to 10,000 shares per trade. Options are $0.60 per contract ($1.00 for index options).
Stocks under $1 per share and trades over 10,000 shares cost $0.005 per share (min $1, max $50).
Futures cost $1.50 per contract per side ($0.50 for micro-futures)—competitive for futures traders.
TradeStation charges a $10 monthly inactivity fee if you don't trade at least 10 times in 90 days or maintain $5,000+ balance. This makes it unsuitable for passive investors.
The $125 outgoing ACAT transfer fee is among the highest in the industry. IRA accounts cost $35 annually.
These fees add up for buy-and-hold investors and reinforce that TradeStation isn't designed for that strategy.
TradeStation's execution quality on stock trades is reported at 91.79%—significantly below the average among brokers.
For active traders where execution matters, this is a notable concern. Fidelity and Schwab consistently report better execution quality.
The platform's strengths are in tools and customization, not execution.
Transparent breakdown of all fees you might encounter.
| Fee Type | Cost |
|---|---|
| Stock & ETF Trades | $0 (up to 10K shares) |
| Options Trades | $0.60/contract |
| Index Options | $1.00/contract |
| Futures | $1.50/contract/side |
| Micro-Futures | $0.50/contract/side |
| Account Minimum | $0 |
| Inactivity Fee | $10/month (waivable) |
| IRA Annual Fee | $35 |
| Dividend Reinvestment (DRIP) | Not Available |
| Account Transfer Out (ACAT) | $125 |
Professional-grade tools, backtesting, and 25% day trading margin requirements.
Competitive futures and micro-futures pricing with advanced platform support.
EasyLanguage and backtesting capabilities for creating automated trading strategies.
TradeStation is an excellent platform for active traders who need professional tools, strategy backtesting, and futures access. However, it's a poor choice for dividend investors due to the lack of DRIP, no fractional shares, and inactivity fees that punish passive investing. If you're building a dividend portfolio, skip TradeStation and choose Fidelity, Schwab, or M1 Finance instead. TradeStation is for traders, not investors.
Compare All PlatformsSee how TradeStation stacks up against the competition
Better for options traders with lower fees and DRIP support.
Read Review →More asset classes and global markets, with DRIP available.
Read Review →DividendScope may earn a commission if you open an account through our links. This doesn't affect our editorial independence—we only recommend platforms we've personally tested and believe are excellent for dividend investors.